MARINUS PHARMACEUTICALS INCMARINUS PHARMACEUTICALS INCMARINUS PHARMACEUTICALS INC

MARINUS PHARMACEUTICALS INC

No trades
See on Supercharts

Price target

22.220.000.00%
The 6 analysts offering 1 year price forecasts for MRNS have a max estimate of — and a min estimate of —.

Analyst rating

Based on 7 analysts giving stock ratings to MRNS in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


MRNS EPS for the last quarter is −8.28 MXN despite the estimation of −8.06 MXN. In the next quarter EPS is expected to reach −6.49 MXN. Track more of MARINUS PHARMACEUTICALS INC financials and stay on top of what is up with the company.
In the next quarter MARINUS PHARMACEUTICALS INC revenue is expected to reach ‪247.04 M‬ MXN. Check out MARINUS PHARMACEUTICALS INC revenue and earnings and make informed decisions.
According to analysts, MRNS price target is 22.22 MXN with a max estimate of 41.67 MXN and a min estimate of 6.25 MXN. Check if this forecast comes true in a year, meanwhile watch MARINUS PHARMACEUTICALS INC stock price chart and keep track of the current situation with MRNS news and stock market news.
We've gathered opinions of 7 analysts rating MRNS stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.